Optiver Holding B.V. Arrowhead Pharmaceuticals, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 622 shares of ARWR stock, worth $25,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
622Holding current value
$25,813% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
339Shares Held
101MCall Options Held
444KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA16MShares$665 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.7MShares$651 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$440 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$264 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$217 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.39B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...